Document Detail


Cardiogenic shock: a summary of the randomized SHOCK trial.
MedLine Citation:
PMID:  12556676     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiogenic shock is the most common cause of death for patients hospitalized with acute myocardial infarction. The Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial randomly assigned 302 patients with predominant left ventricular failure following an acute myocardial infarction to a strategy of emergency revascularization or initial medical stabilization. Emergency revascularization by either coronary artery bypass grafting or angioplasty was required within 6 hours of randomization. Patients assigned to initial medical stabilization could undergo delayed revascularization at a minimum of 54 hours post-randomization. The primary end point of the study was 30-day all-cause mortality. Overall survival at 30 days did not differ significantly between the emergency revascularization and initial medical stabilization groups (53% vs. 44%; p=0.109). However, at the 6- and 12-month follow-up, there was a significant survival benefit with early revascularization (50% vs. 37%; p=0.027 and 47% vs. 34%; p=0.025, respectively). The benefit appeared to be greatest for those less than 75 years of age, with 20 lives saved at 6 months per 100 patients treated. According to the results of the SHOCK trial, the American College of Cardiology/American Heart Association guidelines for myocardial infarction now recommend emergency revascularization for patients younger than 75 years with cardiogenic shock.
Authors:
Venu Menon; Rupert Fincke
Related Documents :
6723316 - Diffuse left ventricular hypokinesis in cardiogenic shock--its cause or consequence?
15216286 - Late ventricular fibrillation following successful resuscitation from postinfarction ca...
19808416 - Sudden death and defibrillators in transposition of the great arteries with intra-atria...
5853296 - A note on time out from avoidance with the chimpanzee.
4071546 - The role of airflow in mucous transport in the trachea.
3709066 - Assessment of the effect of nifedipine on myocardial ischaemia by using the st segment/...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Review    
Journal Detail:
Title:  Congestive heart failure (Greenwich, Conn.)     Volume:  9     ISSN:  1527-5299     ISO Abbreviation:  Congest Heart Fail     Publication Date:    2003 Jan-Feb
Date Detail:
Created Date:  2003-01-30     Completed Date:  2003-04-10     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9714174     Medline TA:  Congest Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  35-9     Citation Subset:  IM    
Copyright Information:
Copyright 2003 CHF, Inc.
Affiliation:
Division of Cardiology, St. Lukes-Roosevelt Hospital Center, Columbia University, 1111 Amsterdam Avenue, New York, NY 10025, USA. vmenon@slrhc.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angioplasty, Transluminal, Percutaneous Coronary
Coronary Artery Bypass
Follow-Up Studies
Humans
Intra-Aortic Balloon Pumping
Research Design
Shock, Cardiogenic / etiology*,  mortality,  therapy*
Survival Analysis
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of angiotensin II receptor blockers in the treatment of heart failure patients.
Next Document:  Hyperthyroidism: a "curable" cause of congestive heart failure--three case reports and a review of t...